DSP Nifty Healthcare Index Fund Direct-Growth
Equity: Sectoral-Pharma - Growth (Open ended)
SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: NIFTY Healthcare Total Return Index.Check Portfolio Overlap →
NAV: ₹10.95-0.83%
23 Oct 2026
Similar Funds
Side-by-side comparison of DSP Nifty Healthcare Index Fund Direct-Growth with similar funds — trailing returns, risk metrics, AUM and expense ratio.
| Period | This Fund | Category Avg | Category Rank |
|---|---|---|---|
| 1Y Return | +2.94% | 6.45% | 16 / 21 |
| 3Y Return | — | 20.20% | — |
| 5Y Return | — | 14.60% | — |
| 10Y Return | — | 14.30% | — |
Trailing annualised returns (%). Category rank: lower is better. Green = top third of category.
Funds in Equity: Sectoral-Pharma
Top funds by AUM in the Equity: Sectoral-Pharma category — see how DSP Nifty Healthcare Index Fund Direct-Growth compares on size and returns.
Funds Tracking NIFTY Healthcare Total Return Index.
Top funds tracking the NIFTY Healthcare Total Return Index. — sorted by AUM to show the largest options available.
Frequently Asked Questions
Which funds are similar to DSP Nifty Healthcare Index Fund Direct-Growth?
Funds similar to DSP Nifty Healthcare Index Fund Direct-Growth in the Equity: Sectoral-Pharma category include Nippon India Pharma Fund Direct-Growth, ICICI Prudential Healthcare Fund Direct-Growth, and SBI Healthcare Opportunities Fund Direct Plan-Growth. These funds follow a comparable investment mandate and are benchmarked against similar indices. You can compare them in detail — across returns, risk metrics, expense ratio, and portfolio composition — using the fund comparison tool on sharpely.
What is the rank of DSP Nifty Healthcare Index Fund Direct-Growth in its category?
The category rank of DSP Nifty Healthcare Index Fund Direct-Growth is shown in the Trailing Returns section above.
How does DSP Nifty Healthcare Index Fund Direct-Growth's expense ratio compare to similar funds?
DSP Nifty Healthcare Index Fund Direct-Growth has an expense ratio of 0.40%. The peers Nippon India Pharma Fund Direct-Growth has an expense ratio of 0.99% and ICICI Prudential Healthcare Fund Direct-Growth has 1.31%. Over the long term, a higher expense ratio can meaningfully drag on returns, so it is worth evaluating whether the fund's performance justifies the additional cost.
How does DSP Nifty Healthcare Index Fund Direct-Growth's AUM compare to similar funds?
DSP Nifty Healthcare Index Fund Direct-Growth has an AUM of ₹24.92 crore. The peers Nippon India Pharma Fund Direct-Growth has an AUM of ₹9,166.4 crore and ICICI Prudential Healthcare Fund Direct-Growth has ₹6,861.2 crore. A large AUM can sometimes limit a fund's ability to take meaningful positions in mid and small-cap stocks, as larger trades can move prices. This is particularly relevant for funds that invest outside large caps.
Which fund has the best 3-year returns in the Equity: Sectoral-Pharma?
The top performing fund in the Equity: Sectoral-Pharma category on a 3-year basis is HDFC Pharma And Healthcare Fund Direct-Growth with a CAGR of 27.94% as of 22 Oct 2026. DSP Nifty Healthcare Index Fund Direct-Growth has delivered - CAGR over the same period. You can view and compare the full category ranking on sharpely.
How does DSP Nifty Healthcare Index Fund Direct-Growth rank in risk-adjusted returns vs peers?
The Sharpe ratio of DSP Nifty Healthcare Index Fund Direct-Growth is shown in the Alpha, Beta & Sharpe section on the Performance tab.